Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Field Sales Leader, Oncology (Scotland, Northern Ireland & North East England) Field Force (Scotland) United Kingdom International Innovative Medicines Sales Sep 27, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
Medical Science Liaison, Immunology Chongqing (Chongqing Province) China International Innovative Medicines Research & Development Sep 30, 2024
Senior Market Access Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Sep 30, 2024
Field Product Specialist - Hue Vietnam Vietnam International Innovative Medicines Sales Oct 16, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
Sales Representative (d/w/m), Rheumatologie,Gebiet: Südhessen Hessen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
(高级)大区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 17, 2024
Sales Value Manager Speciality Care INSURGENTES Mexico International Innovative Medicines Sales Oct 11, 2024
Senior Patient Access Lead Lithuania Lithuania International Innovative Medicines Market Access Oct 14, 2024
Medical Lead Copenhagen Denmark International Innovative Medicines Research & Development Oct 14, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 14, 2024
Territory Business Executive Chandigarh (Territory) India International Innovative Medicines Sales Oct 14, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
QC Senior Scientist Ivrea Italy International Innovative Medicines Research & Development Oct 14, 2024
Territory Sales Manager Cardio: Prague Prague Czech Republic International Innovative Medicines Sales Oct 14, 2024
Therapeutic Area Head Hematology (region LACan) East Hanover USA International Innovative Medicines Commercial & General Management Oct 14, 2024
Product Specialist Selangor Malaysia International Innovative Medicines Sales Oct 15, 2024
Senior Product Specialist Selangor Malaysia International Innovative Medicines Sales Oct 15, 2024
Pharmacy Channel Lead Vietnam Vietnam International Innovative Medicines Marketing Oct 15, 2024
Director, Pricing Basel (City) Switzerland International Innovative Medicines Market Access Oct 15, 2024
Regional Business Manager Bangalore (Office) India International Innovative Medicines Sales Oct 01, 2024
Zonal Business Manager Delhi (Office) India International Innovative Medicines Sales Oct 01, 2024
Zonal Business Manager Mumbai (Head Office) India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Assam India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Maharashtra India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Gujarat India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Telangana India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Kerala India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Delhi Territory India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines Sales Oct 01, 2024
Territory Business Executive Jammu & Kashmir India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines Sales Oct 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines Sales Oct 01, 2024
Pricing Manager Dublin (Country President Office (CPO)) Ireland International CTS Market Access Oct 16, 2024
In-Market Brands Lead Jordan Jordan International Innovative Medicines BD&L & Strategic Planning Oct 16, 2024
Maintenance Specialist Ivrea Italy International Innovative Medicines Technical Operations Oct 16, 2024
Senior Pharmareferent (m/w/d), Onkologie / Urologie / RLT, Gebiet: Rheinland-Pfalz & Saarland Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Marketing Specialist Montreal Canada International Innovative Medicines Marketing Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only